Monograph Capital
Monograph Capital is a transatlantic venture capital firm focused on the life sciences sector. Founded in 2021 and headquartered in London, the firm has operational offices in San Francisco and Dallas-Fort Worth. Led by Dr. Fred Cohen and a team of experienced biotech investors, Monograph Capital aims to identify and fund innovative life sciences companies that can turn scientific discoveries into impactful treatments. The firm typically invests in Series A and Series B rounds, with initial investments ranging from $3 million to $10 million. Monograph Capital not only provides capital but als
Investing activity
Monograph Capital appears in 1 AI deal tracked by the AI Lounge deals desk, rounds totalling $15M, and led 1 of them. The rounds are mostly Series C, with a median round size of $15M. The most recent is Odaia (Series C, $15M, Nov 2026).
Monograph Capital most often invests alongside Publicis Health Media, Innospark Ventures, Wittington Ventures and BDC Capital, and the companies it backs on AI Lounge are mostly in Predictive AI.
Deals
Frequently asked questions about Monograph Capital
What AI companies has Monograph Capital invested in?
Monograph Capital's AI investments include Odaia. The 1 round on AI Lounge are listed on this page with amounts, dates and co-investors.
Where is Monograph Capital based?
Monograph Capital is based in London, England, United Kingdom.
What stage does Monograph Capital invest at?
In the rounds tracked on AI Lounge, Monograph Capital has invested at Series C, with a median round of $15M. Monograph Capital led 1 of those rounds.
Who does Monograph Capital co-invest with?
Monograph Capital's most frequent co-investors on AI Lounge are Publicis Health Media (1 deal), Innospark Ventures (1 deal), Wittington Ventures (1 deal), BDC Capital (1 deal) and Flint Capital (1 deal).
How can founders reach Monograph Capital?
Founders on AI Lounge can see Monograph Capital's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Monograph Capital to their Investor Pipeline to track the conversation.